Luke J Nelson - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|February 2, 2018

Ultrasonic Analytic-Signal Responses From Polymer-Matrix Composite LaminatesRobert A Smith, Luke J Nelson, Martin J Mienczakowski, et al.

The American Journal of Pathology|December 18, 2019

Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast CancersLuke J Nelson, Heather J Wright, Nguyen B Dinh, et al.

Molecular Cancer|March 10, 2009

Molecular assays for the detection of microRNAs in prostate cancerAmara C Siva, Luke J Nelson, Chad L Fleischer, et al.

Molecular Cancer Therapeutics|May 4, 2018

Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent MechanismJordan M Thompson, Alejandro Alvarez, Monika K Singha, et al.

Cell Cycle (Georgetown, Tex.)|March 4, 2022

Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinomaLuke J Nelson, Kyleen E Castro, Binzhi Xu, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|February 2, 2018

Ultrasonic Analytic-Signal Responses From Polymer-Matrix Composite LaminatesRobert A Smith, Luke J Nelson, Martin J Mienczakowski, et al.

The American Journal of Pathology|December 18, 2019

Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast CancersLuke J Nelson, Heather J Wright, Nguyen B Dinh, et al.

Molecular Cancer|March 10, 2009

Molecular assays for the detection of microRNAs in prostate cancerAmara C Siva, Luke J Nelson, Chad L Fleischer, et al.

Molecular Cancer Therapeutics|May 4, 2018

Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent MechanismJordan M Thompson, Alejandro Alvarez, Monika K Singha, et al.

Cell Cycle (Georgetown, Tex.)|March 4, 2022

Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinomaLuke J Nelson, Kyleen E Castro, Binzhi Xu, et al.

Pageof 1